Warning: The NCBI web site requires JavaScript to function. more...
Relationships among age, proinsulin conversion, and beta-cell function in nondiabetic humans.
Fritsche A, Madaus A, Stefan N, Tschritter O, Maerker E, Teigeler A, Häring H, Stumvoll M.
Diabetes. 2002 Feb;51 Suppl 1:S234-9.PMID: 11815485 [PubMed - indexed for MEDLINE]Related articlesFree article
Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and beta-cell dysfunction.
Stumvoll M, Fritsche A, Stefan N, Hardt E, Häring H.
J Clin Endocrinol Metab. 2001 Mar;86(3):1235-9.PMID: 11238514 [PubMed - indexed for MEDLINE]Related articlesFree article
[Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus]
Liu J, Li YB, Shao H, Li YX, Yuan YH, Xiao YB, Weng JP.
Zhonghua Yi Xue Za Zhi. 2007 May 15;87(18):1252-5. Chinese. PMID: 17686259 [PubMed - indexed for MEDLINE]Related articles
The impact of insulin resistance on proinsulin secretion in pregnancy: hyperproinsulinemia is not a feature of gestational diabetes.
Retnakaran R, Hanley AJ, Sermer M, Zinman B.
Diabetes Care. 2005 Nov;28(11):2710-5.PMID: 16249544 [PubMed - indexed for MEDLINE]Related articlesFree article
Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
Festa A, Williams K, Hanley AJ, Haffner SM.
Diabetes. 2008 Jun;57(6):1638-44. Epub 2008 Mar 10.PMID: 18332099 [PubMed - indexed for MEDLINE]Related articlesFree article
A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility.
Fritsche A, Stefan N, Hardt E, Schützenauer S, Häring H, Stumvoll M.
Eur J Clin Invest. 2000 May;30(5):411-8.PMID: 10809901 [PubMed - indexed for MEDLINE]Related articles
Reduced pancreatic B cell compensation to the insulin resistance of aging: impact on proinsulin and insulin levels.
Røder ME, Schwartz RS, Prigeon RL, Kahn SE.
J Clin Endocrinol Metab. 2000 Jun;85(6):2275-80.PMID: 10852463 [PubMed - indexed for MEDLINE]Related articlesFree article
Characterisation of beta-cell dysfunction of impaired glucose tolerance: evidence for impairment of incretin-induced insulin secretion.
Fritsche A, Stefan N, Hardt E, Häring H, Stumvoll M.
Diabetologia. 2000 Jul;43(7):852-8.PMID: 10952457 [PubMed - indexed for MEDLINE]Related articles
Insulin resistance in HIV protease inhibitor-associated diabetes.
Yarasheski KE, Tebas P, Sigmund C, Dagogo-Jack S, Bohrer A, Turk J, Halban PA, Cryer PE, Powderly WG.
J Acquir Immune Defic Syndr. 1999 Jul 1;21(3):209-16.PMID: 10421244 [PubMed - indexed for MEDLINE]Related articles
Functional significance of the UCSNP-43 polymorphism in the CAPN10 gene for proinsulin processing and insulin secretion in nondiabetic Germans.
Stumvoll M, Fritsche A, Madaus A, Stefan N, Weisser M, Machicao F, Häring H.
Diabetes. 2001 Sep;50(9):2161-3.PMID: 11522685 [PubMed - indexed for MEDLINE]Related articlesFree article
Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans.
Quddusi S, Vahl TP, Hanson K, Prigeon RL, D'Alessio DA.
Diabetes Care. 2003 Mar;26(3):791-8.PMID: 12610039 [PubMed - indexed for MEDLINE]Related articlesFree article
One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and alpha- and beta-cell function and reduces endogenous glucose release in patients with type 2 diabetes.
Degn KB, Juhl CB, Sturis J, Jakobsen G, Brock B, Chandramouli V, Rungby J, Landau BR, Schmitz O.
Diabetes. 2004 May;53(5):1187-94.PMID: 15111485 [PubMed - indexed for MEDLINE]Related articlesFree article
Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipients.
Rickels MR, Mueller R, Markmann JF, Naji A.
J Clin Endocrinol Metab. 2009 Jan;94(1):181-9. Epub 2008 Oct 28.PMID: 18957498 [PubMed - indexed for MEDLINE]Related articles
Basal and dynamic proinsulin-insulin relationship to assess beta-cell function during OGTT in metabolic disorders.
Tura A, Pacini G, Kautzky-Willer A, Ludvik B, Prager R, Thomaseth K.
Am J Physiol Endocrinol Metab. 2003 Jul;285(1):E155-62. Epub 2003 Apr 1.PMID: 12670835 [PubMed - indexed for MEDLINE]Related articlesFree article
Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
Greenbaum CJ, Prigeon RL, D'Alessio DA.
Diabetes. 2002 Apr;51(4):951-7.PMID: 11916912 [PubMed - indexed for MEDLINE]Related articlesFree article
The prevalent Glu23Lys polymorphism in the potassium inward rectifier 6.2 (KIR6.2) gene is associated with impaired glucagon suppression in response to hyperglycemia.
Tschritter O, Stumvoll M, Machicao F, Holzwarth M, Weisser M, Maerker E, Teigeler A, Häring H, Fritsche A.
Diabetes. 2002 Sep;51(9):2854-60.PMID: 12196481 [PubMed - indexed for MEDLINE]Related articlesFree article
Stimulatory effect of increased non-esterified fatty acid concentrations on proinsulin processing in healthy humans.
Stefan N, Fritsche A, Madaus A, Häring H, Stumvoll M.
Diabetologia. 2000 Nov;43(11):1368-73.PMID: 11126404 [PubMed - indexed for MEDLINE]Related articles
Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S.
Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE; American Diabetes Association GENNID Study Group.
Diabetes. 2002 Jul;51(7):2170-8.PMID: 12086947 [PubMed - indexed for MEDLINE]Related articlesFree article
Enhancing effects of long-term elevated glucose and palmitate on stored and secreted proinsulin-to-insulin ratios in human pancreatic islets.
Björklund A, Grill V.
Diabetes. 1999 Jul;48(7):1409-14.PMID: 10389846 [PubMed - indexed for MEDLINE]Related articlesFree article
Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects.
Mari A, Schmitz O, Gastaldelli A, Oestergaard T, Nyholm B, Ferrannini E.
Am J Physiol Endocrinol Metab. 2002 Dec;283(6):E1159-66. Epub 2002 Aug 6.PMID: 12388151 [PubMed - indexed for MEDLINE]Related articlesFree article
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on
» See more...